A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ.
Gilheeney SW, et al. Among authors: dunkel ij.
Pediatr Blood Cancer. 2007 Sep;49(3):261-5. doi: 10.1002/pbc.21045.
Pediatr Blood Cancer. 2007.
PMID: 16972243
Clinical Trial.